Carlos Alberto Tagliati

Faculty of Pharmacy of UFMG
Department of Clinical Analysis
Federal University of Minas Gerais
Brazil

Professor Biochemistry
Biography

Pharmacist and Biochemist (habilitation Clinical Analyzes) by the Federal University of Juiz de Fora (1986). He holds a Masters Degree in Toxicology and Toxicological Analysis (1992), PhD in Pharmaceuticals and Medicines (1997), both from the University of São Paulo, and postdoctoral degree in Toxicology In Vitro (2006) from the University of Murcia (Spain). Member of INCT-INOFAR. Founder of the biotechnology company IN VITRO CELLS - PESQUISA TOXICOLÓGICA SA Participated in the creation of the Brazilian Society of Alternative Methods to animal experimentation, being a member of the Fiscal Council. Coordinator of the Laboratory of Experimental Toxicology (in vitro and in vivo) accredited to RENAMA (National Network of Alternative Methods) within the framework of the MCTI (Ministry of Science, Technology and Innovation). Coordinator of the SIMCYP SIMULATOR program (Simcyp Limited, UK). He works in the entrepreneurship sector. It has two technological transfers to the private sector. Professor and adviser of the following postgraduate programs: Clinical and Toxicological Analysis, Bioinformatics, Professional Master's Degree in Technological Innovation and Intellectual Property and Doctorate in Technological and Biopharmaceutical Innovation. Coordinator of the Postgraduate Program in Clinical and Toxicological Analysis. Currently, he is associate professor IV of Toxicology of the Faculty of Pharmacy of the Federal University of Minas Gerais. He has experience in the Pharmacy area, mainly working in the following subjects: pre-clinical toxicity (in vitro and in vivo), nephrotoxicity and toxicokinetics. Clinical and Toxicological Analysis, Bioinformatics, Professional Master's Degree in Technological Innovation and Intellectual Property and PhD in Technological and Biopharmaceutical Innovation. Coordinator of the Postgraduate Program in Clinical and Toxicological Analysis. Currently, he is associate professor IV of Toxicology of the Faculty of Pharmacy of the Federal University of Minas Gerais. He has experience in the Pharmacy area, mainly working in the following subjects: pre-clinical toxicity (in vitro and in vivo), nephrotoxicity and toxicokinetics. Clinical and Toxicological Analysis, Bioinformatics, Professional Master's Degree in Technological Innovation and Intellectual Property and PhD in Technological and Biopharmaceutical Innovation. Coordinator of the Postgraduate Program in Clinical and Toxicological Analysis. Currently, he is associate professor IV of Toxicology of the Faculty of Pharmacy of the Federal University of Minas Gerais. He has experience in the Pharmacy area, mainly working in the following subjects: pre-clinical toxicity (in vitro and in vivo), nephrotoxicity and toxicokinetics. Is associate professor IV of Toxicology of the Faculty of Pharmacy of the Federal University of Minas Gerais. He has experience in the Pharmacy area, mainly working in the following subjects: pre-clinical toxicity (in vitro and in vivo), nephrotoxicity and toxicokinetics. Is associate professor IV of Toxicology of the Faculty of Pharmacy of the Federal University of Minas Gerais. He has experience in the Pharmacy area, mainly working in the following subjects: pre-clinical toxicity (in vitro and in vivo), nephrotoxicity and toxicokinetics.

Research Intrest

Pharmacokinetics and Bioavailability, Preclinical toxicity

List of Publications
FERREIRA, AF ; FRANCE, FD ; ROSSONI, JV; VIANA, PHL; MORAES, KCM ; GOMES, DA; COSTA, DC; TAGLIATI, CA ; KEYS, MM . Cyclic adenosine monophosphate protects renal cell lines against amphotericin B toxicity in a PKA-independent manner. Drug and Chemical Toxicology (New York, NY 1978) , v. 39, p. 1-7, 2015.
LEMOS, FERNANDA O.; VILLALBA, MARIA IMACULADA C.; TAGLIATI, CARLOS A .; CARDOSO, VALBERT N.; LIVES, CARLOS E.; LOPES, MIRIAM TP. Biodistribution, pharmacokinetics and toxicity of a Vasconcellea cundinamarcensis proteinase fraction with pharmacological activity. Brazilian Journal of Pharmacognosy (Printed) , v. 26, p. 94-101, 2015.
DE LIMA TOCCAFONDO VIEIRA, MANUELA; Lídia Moreira Lima ; Barry, EJL ; Tagliati, CA . Investigation of Low Bioavailability Using Physiologically Based Pharmacokinetic Modeling: A Case Example (Lassbio-596). British Journal of Applied Science & Technology, V. 5, p. 613-620, 2015.
MELLOR, CL; ELLISON, CM; ENOCH, SJ; JAIS, DM; MADDEN, JC; SOARES, S.; Tagliati, CA ; CRONIN, MT. Assessment of in silico approaches to predict adverse effects to the kidney and bladder. Toxicology Letters , v. 258, p. S117, 2016.

Global Scientific Words in Biochemistry